BioSpace News Archive

Prior to formally joining AbSci’s Scientific Advisory Board, Dr. Larimore advised AbSci on various aspects of biopharmaceutical process development manufacturing scale-up.

MediSapiens will provide its data curation, data management, data exploration and discovery software solutions to FinnGen, and will be an active technology partner in the project.

West Pharmaceutical Services today announced that the Company’s Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share.

NovaBay announces stockholder approval to issue NovaBay common stock as part of a $10.32 million financing agreement with Ch-gemstone Capital (Beijing) Co., Ltd.

STEGLATRO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

gel-e, a privately held, clinical-stage medical device company, announces the expansion of its Board of Directors to include industry veteran Jim Buck.

Novartis announced today the FDA has accepted the Company’s supplemental sNDA for filing, and granted Priority Review designation for Tafinlar in combination with Mekinist for the adjuvant treatment of patients with stage III melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, following complete resection.

Pending approval, Arrowhead intends to proceed with AROHBV1001, a Phase 1/2 single-dose escalation study to evaluate the safety, tolerability, and pharmacokinetic effects of ARO-HBV in healthy adult volunteers

Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

During this time, the California Department of Public Health will review CSPA’s application and corresponding municipal permits and documentation for a permanent license.